v3.25.2
Share Based Compensation
12 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Share Based Compensation

17 SHARE BASED COMPENSATION

(a) Global Share Plan

On December 9, 2011, the Company’s Board of Directors approved the establishment of Global Share Plan that provides for granting options to eligible directors, employees and etc. (collectively, the “Grantees”) to acquire ordinary shares of the Company at an exercise price as determined by the Board at the time of grant. According to the latest Amended and Restated Global Share Plan, the Board of Directors accumulatively authorized and reserved 384,111,187 ordinary shares for the issuance as of March 31, 2024 and 2025.

Since adoption of the Global Share Plan, the Company granted RSUs and options to the Grantees. All RSUs and options granted have a contractual term of ten years, and the majority vest over a period of four years of continuous service on a straight-line basis. Under the option plan, options are exercisable subject to the grantee’s continuous service and the listing of the stock of the Company on a public stock exchange market or be held in escrow if the employee exercise the vested part when leaving the Company, which is normally in fifteen days after resignation. On December 10, 2018, the Company has consummated its IPO on the New York Stock Exchange.

The Company accounts for share based compensation costs on a straight-line basis over the requisite service period for the award based on the fair value on their respective grant dates.

Valuation of stock options

The Group uses the Binominal option pricing model to estimate the fair value of stock options. The Group estimates the risk free rate based on the yield to maturity of U.S. treasury bonds denominated in US$ at the option valuation date. The exercise multiple is estimated as the ratio of fair value of underlying shares over the exercise price as at the time the option is exercised, based on a consideration of empirical studies on the actual exercise behavior of employees. Expected term is the contract life of the option. The expected volatility at the date of grant date and each option valuation date was estimated based on the historical stock prices of comparable companies. The Group has never declared or paid any cash dividends on its capital stock, and the Group does not anticipate any dividend payments in the foreseeable future. There were no options granted for the years ended March 31, 2023, 2024 and 2025.

 

Summary of option activities under the Global Share Plan

The following table sets forth the summary of option activities under the Company’s Global Share Plan:

 

Number of
share options

 

 

Weighted
Average
Exercise Price

 

 

Weighted Average
Remaining
Contractual Life

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

(US$)

 

 

(In years)

 

 

(US$)

 

Outstanding as of March 31, 2022

 

 

11,950,858

 

 

 

0.11

 

 

 

1.74

 

 

 

 

Expired

 

 

(440,000

)

 

 

0.02

 

 

 

 

 

 

 

Forfeited or cancelled (post-vesting)

 

 

(68,000

)

 

 

0.23

 

 

 

 

 

 

 

Outstanding as of March 31, 2023

 

 

11,442,858

 

 

 

0.11

 

 

 

1.21

 

 

 

 

Expired

 

 

(6,875,185

)

 

 

0.03

 

 

 

 

 

 

 

Forfeited or cancelled (post-vesting)

 

 

(91,300

)

 

 

0.29

 

 

 

 

 

 

 

Outstanding as of March 31, 2024

 

 

4,476,373

 

 

 

0.23

 

 

 

1.59

 

 

 

 

Expired

 

 

(890,000

)

 

 

0.15

 

 

 

 

 

 

 

Forfeited or cancelled (post-vesting)

 

 

(615,073

)

 

 

0.06

 

 

 

 

 

 

 

Outstanding as of March 31, 2025

 

 

2,971,300

 

 

 

0.29

 

 

 

1.09

 

 

 

 

Vested and expected to vest as of March 31, 2025

 

 

2,971,300

 

 

 

0.29

 

 

 

1.09

 

 

 

 

Exercisable as of March 31, 2025

 

 

2,971,300

 

 

 

0.29

 

 

 

1.09

 

 

 

 

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the estimated fair value of the underlying stock at each reporting date.

The Company recognized no share-based compensation expenses for share options granted under the Global Share Plan in the Consolidated Statements of Operations and Comprehensive Loss for the years ended March 31, 2023, 2024 and 2025, respectively.

As of March 31, 2024 and 2025, there was no unrecognized compensation expense in relation to the share options.

(b) Service-based RSUs

A summary of activities of the service-based RSUs for the years ended March 31, 2023, 2024 and 2025 is presented below:

 

Number of RSUs

 

 

Weighted-Average
Grant-Date Fair Value

 

 

 

 

 

US$

 

Unvested at March 31, 2022

 

 

31,889,050

 

 

 

0.10

 

Granted

 

 

132,327,600

 

 

 

0.01

 

Vested

 

 

(81,298,225

)

 

 

0.04

 

Forfeited

 

 

(400,875

)

 

 

0.07

 

Unvested at March 31, 2023

 

 

82,517,550

 

 

 

0.01

 

Vested

 

 

(42,129,300

)

 

 

0.03

 

Forfeited

 

 

(186,000

)

 

 

0.04

 

Unvested at March 31, 2024

 

 

40,202,250

 

 

 

0.01

 

Vested

 

 

(38,389,025

)

 

 

0.01

 

Forfeited

 

 

(154,875

)

 

 

0.07

 

Unvested at March 31, 2025

 

 

1,658,350

 

 

 

0.02

 

 

For the years ended March 31, 2023, 2024 and 2025, total share-based compensation expenses recognized by the Group for the service-based RSUs granted were RMB13,563, RMB4,590 and RMB839, respectively.

As of March 31, 2024 and 2025, there were RMB920 and RMB80 of unrecognized share-based compensation expenses related to the service-based RSUs granted which is expected to be recognized over a weighted-average period of 2.10 and 0.34 years.

The total fair value and intrinsic value of RSUs vested was RMB3,646, RMB2,036 and RMB1,872 during the years ended March 31, 2023, 2024 and 2025, respectively.